5JEHA S, GAYNON PS, RAZZOUK BI, et al. Phase Ⅱ study of elofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia [J]. J Clin Oncol, 2006, 24 (12): 1917-1923.
6PUI CH, PEI D, SANDLUND JT, et al. Risk of adverse events after completion of therapy for childhood acute lymphoblastie leukemia [J]. J Clin Oncol, 2005, 23 (31 ) : 7936-7941.
7SADOWITZ PD, SMITH SD, SHUSTER J, et al. Treatment of late bone marrow relapse in children with acute lymphoblastic leukemia: a Pediatric Oncology Group Study [J]. Blood, 1993, 81(3): 602-609.
8PUI CH, JEHA S, KIRKPATRICK P. Clofarabine [J]. Nat Rev Drug Discov, 2005, 4(5): 369-370.
9GENINI D, ADACHI S, CHAO Q, et al. Deoxyadenosine analogs induce programmed cell death in chronic lymphocytic leukemia cells by damaging the DNA and by directly affecting the mitochondria [J]. Blood, 2000, 96(10): 3537-3543.
10ROBAK T, LECH-MARANDA E, KORYCKA A, et al. Purine nucleoside analogs as immunosuppressive and antineoplastic agents: mechanism of action and clinical activity [J]. Curt Med Chem, 2006, 13(26) : 3165-3189.
